We then evaluated cell lines and SCLC patient tumors for association between high E-cadherin levels or low EMT scores, respectively and a curated list of genes known to be markers of cancer stem cells [29, 30], involved in EMT [31], and associated with tumor progression in SCLC [32]. This evidence concerns the gene CDH1 and neoplasm.